Ceres and District Environment and Amenity Protection Group


Ceres - No to Ceres Wind Farm

About Us

Ceres and District Environment and Amenity Protection Group addresses issues arising from planning applications that adversely effect the environment and amenity of the area. We address these issues on relevant planning grounds and use Scottish national policy and the Fife development plan as our guide.

Today in JAMA The results are published online.

Related StoriesStudy displays uncommon HER2 missense mutations do not spread breast cancer on their ownViralytics enters into scientific trial collaboration contract with MSDNew RNA test of blood platelets may be used to detect location of cancer.. Childhood cancer survivors at increased risk of new cancers in middle age CANCER RESEARCH UK scientists have found that survivors of childhood cancers are 4 times more likely than the general population to develop a new cancer. Today in JAMA The results are published online. Continue reading

Call for greater beta blocker use in COPD By Kirsty Oswald.

Licensed from medwireNews with authorization from Springer Health care Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.. Call for greater beta blocker use in COPD By Kirsty Oswald, medwireNews Reporter Researchers say that stubbornly low rates of beta-blocker prescribing in sufferers with chronic obstructive pulmonary disease could possibly be contributing toward increased mortality in these individuals following myocardial infarction. Continue reading

NOH is a problem of the nervous system resulting from a deficient release of norepinephrine.

Related StoriesEnvironmental factors may lead to development of some childhood cancersGDF10 molecule defined as an integral player in restoration mechanisms after strokeLiposomal sizing and the Coulter theory: an interview with Professor Melvin E. Klegerman We are delighted to reach our focus on enrollment in Study 301 and so are assured the trial will capture the full therapeutic advantage of Northera in symptomatic NOH, commented Dr. Simon Pedder, president and CEO of Chelsea Therapeutics. We are grateful to all or any the clinicians and sufferers for their continued strong support and participation in this trial. We look forward to seeing the top-line outcomes from this trial in September and continuing to utilize the clinical investigators and their employees throughout the year to complete our various other on-going Phase III trial and document a new drug application next calendar year. Continue reading

The oxygen-carrying protein inside crimson blood cells.

Nevertheless, some problems may appear with having bloodstream drawn, including: feeling or fainting lightheaded hematoma pain connected with multiple punctures to discover a vein Helping Your Child Having a blood check is relatively painless. Still, many kids fear so much needles. Explaining the check in terms your son or daughter can understand will help ease a few of the fear. Allow your son or daughter to ask the specialist any questions she or he might have. Tell your child to attempt to loosen up and stay still through the procedure, as tensing muscle groups and moving makes it harder and even more painful to attract blood. Continue reading

Malignancy Control: Are We FINALLY Gaining the Upper Hand?

It is necessary when practicing any kind of cancers control that you talk about all of your options with a health care provider so you can find the right treatment for the body. Cancer control is vital that you follow when you are coping with any type or kind of tumor, especially those within the bone. The research on this cancer is relatively young still, but more options are being discovered. Now people can receive genetic assessment to see if they’re at risk for a specific cancer. Genetics can help a person find where faults can be found when cells reproduce within their body. But genetic testing can only just carry someone so far. Lifestyle should constitute the remaining role in malignancy control methods.. Continue reading

Is very happy to announce the full total results of a report released this week in Critical Care

Biomarker plasma NGAL suggested to boost clinical medical diagnosis of AKI in the crisis department Alere Inc. Is very happy to announce the full total results of a report released this week in Critical Care, demonstrating that plasma neutrophil gelatinase-connected lipocalin , a biomarker that supports the early recognition of acute kidney damage , improved the medical diagnosis of AKI when put into clinical judgment. Individuals presenting to the crisis department may have problems with AKI that’s not yet clinically obvious . Salvatore di Somma, M.D., at the San Andrea Medical center, Rome, Italy, studied whether pNGAL amounts could provide info that enhanced the original medical judgment of ED doctors when used with all the standard – of-treatment parameters for assessing AKI. Continue reading